Health Technology · Pharmaceuticals: Major · NSE: BAJAJHCARE · data 2026-10-09
Bajaj Healthcare Ltd
Health check: Weak (3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹320
Market cap
₹1,062 cr
P/E
60.5
P/B
—
ROE
4.3%
ROCE
13.2%
Debt / equity
0.47
Dividend yield
0.48%
1-year return
-31.9%
52-week high
₹490
52-week low
₹272.35
Operating margin
12.8%
Growth
| Revenue (last 12 months) | ₹628 cr |
| Net profit (last 12 months) | ₹18 cr |
| Sales growth, 3 years (yearly) | -1.8% |
| Profit growth, 3 years (yearly) | -28.4% |
Chart patterns
- Double top — forming (key level ₹313.05)
Similar companies
Remus Pharmaceuticals Ltd. (REMUS) · Lincoln Pharmaceuticals Ltd (LINCOLN) · Sigachi Industries Limited (SIGACHI) · Themis Medicare Limited (THEMISMED) · Bafna Pharmaceuticals Limited (BAFNAPH)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BAJAJHCARE in NSE Scanner →